This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

ThyssenKrupp’s submarine training patent bid dismissed amid defense expansion

By Inbar Preiss ( March 20, 2025, 18:12 GMT | Insight) -- The European Patent Office’s Board of Appeal has rejected ThyssenKrupp’s attempt to secure a patent for its submarine crew training simulator, upholding the Examining Division’s finding that it lacked an inventive step. The board determined that while the prior art did not explicitly disclose all aspects of ThyssenKrupp’s design, the proposed modifications were considered obvious to a skilled person. The decision comes as ThyssenKrupp Marine Systems prepares to expand its military manufacturing capacity in response to Germany’s increased defense spending.Thyssenkrupp and Thyssenkrupp Marine Systems' appeal concerning its patent application for a submarine crew training simulator has been rejected by the European Patent Office's Board of Appeal, according to a document published this week....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login